Miss Ruth Hagen
Research Assistant
Department of Microbiology and Immunology
14 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity.
DOI: 10.1038/s41467-026-73988-z2026
Journal article
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses
DOI: 10.1126/scitranslmed.aea86212025
Journal article
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures
DOI: 10.1038/s41467-025-65262-52025
Journal article
HLA-B*15:01-positive severe COVID-19 patients lack CD8 T cell pools with highly expanded public clonotypes
DOI: 10.1073/pnas.25031451222024
Journal article
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
DOI: 10.1136/rmdopen-2024-0046642024
Journal article
SARS-CoV-2-specific CD8 T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
DOI: 10.1073/pnas.24114281212024
Journal article
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
DOI: 10.1136/jnnp-2023-332224
RECENT SCHOLARLY WORKS
2024
Journal article
Methodological optimisation of thymocyte isolation and cryopreservation of human thymus samples
DOI: 10.1016/j.jim.2024.1136512024
Journal article
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8 T cell responses
DOI: 10.1016/j.jaut.2024.1031752022
Journal article
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
DOI: 10.1212/NXI.0000000000001178